DDCs: Programmable Cancer Drug Delivery

Stephen explains DNA drug conjugates that require multiple biomarkers to activate, reducing off-target toxicity.

Play episode from 56:32

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!